Jose M. Rubio, MD
The Zucker Hillside Hospital, Northwell Health, Department of Psychiatry, Glen Oaks, New York; Department of Psychiatry, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York; Feinstein Institutes for Medical Research, Institute of Behavioral Science, Manhasset, New York
Review Article
Outcomes of NMS With Depot Versus Oral Antipsychotics
November 24, 2020
Is the advantage of longer-term medication release with long-acting injectable antipsychotics offset by an increased risk of more prolonged and severe neuroleptic malignant syndrome? This systematic review and pooled...
ASCP Corner
Nonpsychotic Psychiatric Disorders and Substance Use Disorders
April 26, 2017
This month's ASCP Corner discusses the significant problem of untreated psychiatric disorders and substance use disorders. The authors review the association between untreated illness and morbidity/mortality, look at ways...
ASCP Corner
Duration and Relevance of Untreated Psychiatric Disorders, 1: Psychotic Disorders
March 29, 2017
This month's ASCP Corner discusses the significant problem of untreated psychosis. The authors review the factors that contribute to a longer time to treatment, the impact of untreated psychosis,...
